In 2020, the number of personalized medicines found at in the United States were around 286.
Increasing Use of Nanobots in Drug Delivery
The growing use of nanobots in drug delivery applications is expected to support the market growth. Normally, drugs work through the entire body before they reach the disease affected area. Nanobots help in targeted drug delivery to the precise location, making the drug more effective and reducing the chances of side effects. Nanobots used in drug delivery have walls that are just 5–10 atoms thick and the inner drug-filled cell is usually 50–100 nm wide. When they detect signs of the disease, thin wires in their walls emit an electrical pulse which causes the walls to dissolve and the drug to be released. Using this method of drug delivery, the amount and time of drug release can be easily controlled by controlling the electric pulse.
Increasing Research & Developments
The growing research & developments in the field of nanotechnology and nanobots is expected to create lucrative opportunities for the market growth. Various academic & research institutions and biotechnology & pharmaceutical companies are researching and developing new nanobots that could address different needs of the nanobots market. Additionally, research is being carried out to advance and improve the functioning of existing nanobots also. All this is leading to launch of clinical trials and is attracting a lot of fundings and investments, thereby creating new prospects of growth for global nanobots market. For instance, in February 2021, Tescan-Orsay announced the launch of nanomanipulator for applications performed in Tescan scanning electron microscope and FIB-SEM instruments.
Download Free Sample Report
Market Segmentation
It is projected that by the end of 2022, the United States would be generating a revenue of around USD8.11 billion from scientific research & development activities.
Market Players
Ginkgo Bioworks Inc., Imina Technologies S.A., Thermo Fischer Scientific, Inc., EV Group, Zymergen Inc., Nanoics Imaging Limited, Synthace Limited, Toronto Nano Instrumentation Inc., Oxford Instruments plc, Bruker Corporation
Attribute | Details |
Base Year | 2021 |
Historic Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · By Type · By Application · By Region |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Egypt; Turkey |
Key companies profiled | Ginkgo Bioworks Inc., Imina Technologies S.A., Thermo Fischer Scientific, Inc., EV Group, Zymergen Inc., Nanoics Imaging Limited, Synthace Limited, Toronto Nano Instrumentation Inc., Oxford Instruments plc, Bruker Corporation |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |